Navigation Links
International collaboration finds 11 new Alzheimer's genes to target for drug discovery
Date:10/27/2013

MIAMI -- University of Miami Miller School of Medicine researchers played a key role in the largest international Alzheimer's disease genetics collaboration to date, which identified 11 new regions of the genome that contribute to late-onset Alzheimer's disease, doubling the number of potential genetics-based therapeutic targets to investigate. Published October 27 in Nature Genetics, the study gives a broader view of the genetic factors contributing to Alzheimer's and expands the understanding of the disease to new areas, including the immune system, where a genetic overlap with other neurodegenerative diseases, including multiple sclerosis and Parkinson's disease, was identified.

In 2011, the world's four largest research consortia on the genetics of Alzheimer's disease joined efforts to discover and map the genes that contribute to Alzheimer's, forming the International Genomics of Alzheimer's Project (IGAP). The team collected genetic information from 25,500 Alzheimer's disease patients and 49,038 controls from 15 countries to perform this two-stage meta-analysis that resulted in the discovery of 11 new genes in addition to those already known, and the identification of 13 other genes, yet to be validated.

Margaret A. Pericak-Vance, Ph.D., the Dr. John T. Macdonald Foundation Professor of Human Genomics and Director of the John P. Hussman Institute for Human Genomics at the Miller School, and Lindsay A. Farrer, Ph.D., from Boston University, led the analysis teams for the American Alzheimer's Disease Genetics Consortium, which includes nearly all of the nation's researchers working on the genetics of Alzheimer's, as well as many investigators and resources of the 29 federally funded Alzheimer's Disease Centers.

Several of the genes the researchers identified confirmed known biological pathways of Alzheimer's disease, including the role of the amyloid (SORL1, CASS4) and tau (CASS4, FERMT2) pathways. Newly discovered genes involved in the immune response and inflammation (HLA-DRB5/DRB1, INPP5D, MEF2C) reinforced a pathway implied by previous work (on CR1, TREM2). Additional genes related to cell migration (PTK2B), lipid transport and endocytosis (SORL1) also were confirmed, and new hypotheses emerged related to hippocampal synaptic function (MEF2C, PTK2B), the cytoskeleton and axonal transport (CELF1, NME8, CASS4), as well as myeloid and microglial cell functions (INPP5D).

One of the more significant new associations was found in the HLA-DRB5/DRB1 region, one of the most complex parts of the genome, which plays a role in the immune system and inflammatory response. It also has been associated with multiple sclerosis and Parkinson's disease, suggesting that the diseases where abnormal proteins accumulate in the brain may have a common mechanism involved, and possibly a common drug target.

"The discovery of novel pathways is very encouraging considering the limited success of Alzheimer's disease drugs tested so far," Pericak-Vance said. "Our findings bring us closer toward identifying new drug targets for Alzheimer's and other neurodegenerative diseases. We'll continue to expand and analyze our data set with this incredible group so that we can better understand the genetic influences on this devastating disease, and find new medical and therapeutic interventions."


'/>"/>

Contact: Alexandra Bassil
a.bassil@miami.edu
305-284-1092
University of Miami
Source:Eurekalert

Related biology news :

1. PETA and its international affiliates launch not-for-profit international science company
2. Stepping up the Pace: 20th International AIDS Conference (AIDS 2014) theme selected
3. International Niels Bohr Conference: An open world
4. Celiac research to highlight international symposium
5. New research on potential avocado health benefits presented at International Congress of Nutrition
6. International experts to explore new wonderdrug at conference
7. International Rett Syndrome Foundation chief science officer receives prestigious military awards
8. SmartMove, Inc. receives $200,000 grant from the Colorado Office of Economic Development and International Trade
9. Researchers describe potential for MERS coronavirus to spread internationally
10. UChicago Celiac Disease Center to host international symposium
11. MARC travel awards announced for the GSA: 19th International C. elegans Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/13/2018)... (PRWEB) , ... November 13, 2018 , ... Kenall has ... White and reading light options. These redesigned linear overbed luminaires are equipped with symmetric ... the ingress of water and dust. , Intended to be specified in pairs, the ...
(Date:11/7/2018)... ... November 07, 2018 , ... Features ... to adjust to last-minute changes all contribute to client retention and referral business ... patient travel and expense services provider says 80 percent of its new business ...
(Date:11/6/2018)... , ... November 06, 2018 , ... uBiome, the leader ... and Biophysics at the University of California, San Francisco (UCSF) and Co-President of Chan ... scientific adviser to uBiome since 2013, and we are honored that he is expanding ...
Breaking Biology News(10 mins):
(Date:10/25/2018)... ... October 24, 2018 , ... To prepare for radiological ... it will work Argentum Medical, LLC to repurpose its commercial Silverlon ... silver technology, the privately held company has been awarded a three-year, $8.4 million contract ...
(Date:10/24/2018)... ... October 22, 2018 , ... ... scientists, clinicians, and medical experts from around the world, will host its first ... focus on best practices in testing, chromatography, centrifugation, as well as developments in ...
(Date:10/18/2018)... HAYWARD, Calif. (PRWEB) , ... October 18, 2018 ... ... its CLIA-certified genomic sequencing laboratory in the San Francisco Bay Area has received ... in quality, operations, and patient safety. , Predicine received CAP accreditation for its ...
(Date:10/17/2018)... N.J. (PRWEB) , ... October 17, 2018 , ... ... delivery technologies and development solutions for drugs, biologics and consumer health products, today ... Applied Drug Delivery Institute, will present at the annual Partnership Opportunities in Drug ...
Breaking Biology Technology: